Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03586661
Title Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

peritoneum cancer

fallopian tube cancer

endometrial adenocarcinoma

ovary serous adenocarcinoma

Therapies

Copanlisib + Niraparib

Age Groups: adult senior


No variant requirements are available.